{"id":"https://openalex.org/W136513817","doi":null,"title":"Antisense and RNAi: powerful tools in drug target discovery and validation.","display_name":"Antisense and RNAi: powerful tools in drug target discovery and validation.","publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W136513817","mag":"136513817","pmid":"https://pubmed.ncbi.nlm.nih.gov/12951819"},"language":"en","primary_location":{"id":"pmid:12951819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12951819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049601131","display_name":"Karen Lavery","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen S Lavery","raw_affiliation_strings":["Sequitur Inc., 14 Tech Circle, Natick, MA 01060, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sequitur Inc., 14 Tech Circle, Natick, MA 01060, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104109868","display_name":"Thomas H. King","orcid":"https://orcid.org/0009-0005-8764-4937","observed_orcids":["https://orcid.org/0009-0005-8764-4937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas H King","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2628,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.88027815,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"6","issue":"4","first_page":"561","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9911999702453613,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9259999990463257},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-target-validation","display_name":"drug target validation","score":0.9139999747276306},{"id":"https://openalex.org/keywords/loss-of-function-phenotypes","display_name":"loss-of-function phenotypes","score":0.6990000009536743},{"id":"https://openalex.org/keywords/mrna-cleavage","display_name":"mRNA cleavage","score":0.8679999709129333},{"id":"https://openalex.org/keywords/high-throughput-screening","display_name":"high-throughput screening","score":0.8479999899864197},{"id":"https://openalex.org/keywords/in-vivo-disease-models","display_name":"in vivo disease models","score":0.8330000042915344},{"id":"https://openalex.org/keywords/antisense-therapeutics","display_name":"antisense therapeutics","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C166703698","wikidata":"https://www.wikidata.org/wiki/Q201993","display_name":"RNA interference","level":4,"score":0.7707977294921875},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.7398510575294495},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5597591996192932},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.5326145887374878},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.5061292052268982},{"id":"https://openalex.org/C51323132","wikidata":"https://www.wikidata.org/wiki/Q626251","display_name":"High-throughput screening","level":2,"score":0.4691428542137146},{"id":"https://openalex.org/C6555983","wikidata":"https://www.wikidata.org/wiki/Q7181398","display_name":"Phenotypic screening","level":4,"score":0.44043776392936707},{"id":"https://openalex.org/C206345919","wikidata":"https://www.wikidata.org/wiki/Q20380951","display_name":"Resource (disambiguation)","level":2,"score":0.41963517665863037},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41838592290878296},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.4180909991264343},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.4166225790977478},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3095175623893738},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2535396218299866},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.20864936709403992},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1910218596458435},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1866951286792755},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.1665249764919281},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11386474967002869},{"id":"https://openalex.org/C119857082","wikidata":"https://www.wikidata.org/wiki/Q2539","display_name":"Machine learning","level":1,"score":0.07891640067100525},{"id":"https://openalex.org/C31258907","wikidata":"https://www.wikidata.org/wiki/Q1301371","display_name":"Computer network","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016372","descriptor_name":"RNA, Antisense","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034622","descriptor_name":"RNA Interference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12951819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12951819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in drug discovery & development","raw_type":"Journal Article"},{"id":"mag:136513817","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12951819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2064063908","https://openalex.org/W4385495024","https://openalex.org/W2087257928","https://openalex.org/W1976535454","https://openalex.org/W132877042","https://openalex.org/W2002055086","https://openalex.org/W7140242965","https://openalex.org/W2416704227","https://openalex.org/W2054136046","https://openalex.org/W1752110560"],"abstract_inverted_index":{"Drug":[0],"target":[1,31,55,69,133],"discovery":[2,56],"and":[3,13,40,57,63,96,124,126],"validation":[4],"are":[5,45,108,131],"complex":[6],"processes":[7],"that":[8,24],"require":[9],"significant":[10],"resource":[11],"investments":[12],"impose":[14],"a":[15,68,82],"substantial":[16],"economic":[17],"burden":[18],"on":[19,81],"the":[20,28,74,77,139],"pharmaceutical":[21],"industry.":[22],"Technologies":[23],"accelerate":[25],"or":[26],"enhance":[27],"precision":[29],"of":[30,53,67,73,76,86,138],"selection":[32,134],"are,":[33],"therefore,":[34],"in":[35,50,92,97],"high":[36],"demand.":[37],"Traditional":[38],"antisense":[39,123],"RNA":[41],"interference":[42],"(RNAi)":[43],"technologies":[44,88,130],"powerful":[46],"tools":[47],"with":[48],"applications":[49],"multiple":[51],"phases":[52],"drug":[54,140],"validation.":[58],"These":[59],"approaches":[60],"elicit":[61],"potent":[62],"highly":[64],"selective":[65],"cleavage":[66],"mRNA,":[70],"permitting":[71],"evaluation":[72],"role":[75],"corresponding":[78],"protein":[79],"based":[80],"loss-of-function":[83],"phenotype.":[84],"Incorporation":[85],"these":[87,113,129],"into":[89,104],"high-throughput":[90],"screens,":[91],"vitro":[93],"biological":[94],"assays":[95],"vivo":[98],"disease":[99],"models":[100],"provides":[101],"valuable":[102],"insight":[103],"gene":[105],"function.":[106],"Efforts":[107],"also":[109],"underway":[110],"to":[111],"develop":[112],"agents":[114],"as":[115],"drugs.":[116],"This":[117],"review":[118],"presents":[119],"recent":[120],"studies":[121],"involving":[122],"RNAi,":[125],"discusses":[127],"how":[128],"facilitating":[132],"at":[135],"various":[136],"stages":[137],"development":[141],"process.":[142]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}